These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29331037)

  • 1. Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.
    Anderegg MD; Gums TH; Uribe L; MacLaughlin EJ; Hoehns J; Bazaldua OV; Ives TJ; Hahn DL; Coffey CS; Carter BL
    Pharmacotherapy; 2018 Mar; 38(3):309-318. PubMed ID: 29331037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH.
    Carter BL
    J Manag Care Pharm; 2004 Sep; 10(5 Suppl A):S18-25. PubMed ID: 15369421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician and pharmacist collaboration to improve blood pressure control.
    Carter BL; Ardery G; Dawson JD; James PA; Bergus GR; Doucette WR; Chrischilles EA; Franciscus CL; Xu Y
    Arch Intern Med; 2009 Nov; 169(21):1996-2002. PubMed ID: 19933962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial.
    Margolis KL; Asche SE; Bergdall AR; Dehmer SP; Groen SE; Kadrmas HM; Kerby TJ; Klotzle KJ; Maciosek MV; Michels RD; O'Connor PJ; Pritchard RA; Sekenski JL; Sperl-Hillen JM; Trower NK
    JAMA; 2013 Jul; 310(1):46-56. PubMed ID: 23821088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care-based, pharmacist-physician collaborative medication-therapy management of hypertension: a randomized, pragmatic trial.
    Hirsch JD; Steers N; Adler DS; Kuo GM; Morello CM; Lang M; Singh RF; Wood Y; Kaplan RM; Mangione CM
    Clin Ther; 2014 Sep; 36(9):1244-54. PubMed ID: 25085406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.
    Cooney D; Moon H; Liu Y; Miller RT; Perzynski A; Watts B; Drawz PE
    BMC Nephrol; 2015 Apr; 16():56. PubMed ID: 25881226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
    Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
    J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained blood pressure control following discontinuation of a pharmacist intervention.
    Wentzlaff DM; Carter BL; Ardery G; Franciscus CL; Doucette WR; Chrischilles EA; Rosenkrans KA; Buys LM
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):431-7. PubMed ID: 21649843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pharmacist intervention for blood pressure control in patients with chronic kidney disease: A meta-analysis of randomized clinical trials.
    Nakanishi M; Mizuno T; Mizokami F; Koseki T; Takahashi K; Tsuboi N; Katz M; Lee JK; Yamada S
    J Clin Pharm Ther; 2021 Feb; 46(1):114-120. PubMed ID: 32949161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
    Padiyara RS; D'Souza JJ; Rihani RS
    J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster-randomized trial of a physician/pharmacist collaborative model to improve blood pressure control.
    Carter BL; Coffey CS; Ardery G; Uribe L; Ecklund D; James P; Egan B; Vander Weg M; Chrischilles E; Vaughn T
    Circ Cardiovasc Qual Outcomes; 2015 May; 8(3):235-43. PubMed ID: 25805647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial to assess pharmacist- physician collaborative practice in the management of metabolic syndrome in a university medical clinic in Jordan.
    Hammad EA; Yasein N; Tahaineh L; Albsoul-Younes AM
    J Manag Care Pharm; 2011 May; 17(4):295-303. PubMed ID: 21534640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial.
    Green BB; Cook AJ; Ralston JD; Fishman PA; Catz SL; Carlson J; Carrell D; Tyll L; Larson EB; Thompson RS
    JAMA; 2008 Jun; 299(24):2857-67. PubMed ID: 18577730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.
    Carter BL; Bergus GR; Dawson JD; Farris KB; Doucette WR; Chrischilles EA; Hartz AJ
    J Clin Hypertens (Greenwich); 2008 Apr; 10(4):260-71. PubMed ID: 18401223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deterioration of blood pressure control after discontinuation of a physician-pharmacist collaborative intervention.
    Carter BL; Doucette WR; Franciscus CL; Ardery G; Kluesner KM; Chrischilles EA
    Pharmacotherapy; 2010 Mar; 30(3):228-35. PubMed ID: 20180606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
    McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
    Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.
    Polgreen LA; Han J; Carter BL; Ardery GP; Coffey CS; Chrischilles EA; James PA
    Hypertension; 2015 Dec; 66(6):1145-51. PubMed ID: 26527048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental costs associated with physician and pharmacist collaboration to improve blood pressure control.
    Kulchaitanaroaj P; Brooks JM; Ardery G; Newman D; Carter BL
    Pharmacotherapy; 2012 Aug; 32(8):772-80. PubMed ID: 23307525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.